1. Hospitalization for Invasive Pneumococcal Diseases in Young Children before Use of 13-Valent Pneumococcal Conjugate Vaccine, Suzhou, China
- Author
-
Jian Xue, Yunzhen Tao, Xiyan Zhang, Xuejun Shao, Jianmei Tian, Shuang Feng, Yunzhong Wang, Tao Zhang, Kaile Chen, Changpeng Liu, Yongdong Yan, Qinghui Chen, and Genming Zhao
- Subjects
Serotype ,Pediatrics ,Epidemiology ,lcsh:Medicine ,PCV13 ,medicine.disease_cause ,Pneumococcal conjugate vaccine ,Pneumococcal Vaccines ,0302 clinical medicine ,Invasive pneumococcal diseases ,030212 general & internal medicine ,Child ,bacteria ,Incidence ,Incidence (epidemiology) ,pneumococcal conjugate vaccines ,meningitis ,PCV7 ,vaccines ,Hospitalization ,Pneumococcal infections ,Streptococcus pneumoniae ,Infectious Diseases ,streptococci ,Child, Preschool ,Meningitis ,medicine.drug ,Microbiology (medical) ,China ,medicine.medical_specialty ,incidence of hospitalization ,Pneumococcal disease ,030231 tropical medicine ,Pneumococcal Infections ,lcsh:Infectious and parasitic diseases ,03 medical and health sciences ,Hospitalization for Invasive Pneumococcal Diseases in Young Children before Use of 13-Valent Pneumococcal Conjugate Vaccine, Suzhou, China ,medicine ,Humans ,lcsh:RC109-216 ,Vaccines, Conjugate ,business.industry ,Research ,lcsh:R ,Infant ,Baseline data ,bacterial infections and mycoses ,medicine.disease ,Suzhou ,business - Abstract
A 13-valent pneumococcal conjugate vaccine against invasive pneumococcal disease (IPD) was introduced in China in April 2017. We describe 105 children
- Published
- 2021
- Full Text
- View/download PDF